M. J. Biopharm Private Limited, a active private limited company, was established on 27 June 2002 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234PN2002PTC158855. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹23.01 Cr.
Formerly known as Mj Biotech Private Limited, Shreya Biotech Private Limited. It upholds a compliant status. Employing 315 professional, Its leadership includes Amol Jashvant Shah (Managing Director), Dhaval Vipin Vashi (Director), Pheroze Kersasp Mistry (Nominee Director). Past directors included Amol Jashvant Shah, Jashvant Mansukhlal Shah, Saul Mashaal. It holds ₹170.00 Cr open charges and ₹42.78 Cr settled loans. Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 18, It Park, Hinjawadi Phase Ii, Near Emcure Industrial,, Pune, Maharashtra, 411057.
U24234PN2002PTC158855
158855
27 June 2002
₹40.00 Cr
₹23.01 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into M. J. Biopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amol Jashvant Shah | Managing Director | 28 Jun 2019 | Current |
| Dhaval Vipin Vashi | Director | 28 Jun 2019 | Current |
| Pheroze Kersasp Mistry | Nominee Director | 04 May 2018 | Current |
| Kajal Amol Shah | Director | 24 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2015 | Past |
| Pramod Abcsdd | Director | 18 Aug 2009 | Past |
| Pramod Abcsdd | Director | 29 Sep 2007 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
M. J. Biopharm Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 31.11% increase. The company also saw a slight improvement in profitability, with a 9.55% increase in profit. The company's net worth moved up by a moderate rise of 9.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, M. J. Biopharm had a promoter holding of 70.00% and a public holding of 30.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,700,000,000.00
₹427,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2022 | Sbicap Trustee Company Limited | ₹170.00 Cr | Open |
| 04 Dec 2015 | Others | ₹3.00 Cr | Satisfied |
| 17 Nov 2015 | Icici Bank Limited | ₹5.00 Cr | Satisfied |
| 09 Jan 2014 | Icici Bank Limited | ₹2.50 Cr | Satisfied |
| 20 Dec 2013 | Icici Bank Limited | ₹12.00 Cr | Satisfied |
Explore comprehensive loan charge details -
M. J. Biopharm has a workforce of 315 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of M. J. Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. J. Biopharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Sbicap Trustee Company Limited of Rs. 170.00 Cr registered on 31 May 2022 with Charge ID 100581744 was modified on 08 Oct 2025. was completed.
M. J. Biopharm Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity M. J. Biopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Progress on A charge registered on 17 Nov 2015 via Charge ID 10606925 with Icici Bank Limited was fully satisfied on 21 Jul 2022. was documented.
A charge registered on 20 Dec 2013 via Charge ID 10477031 with Icici Bank Limited was fully satisfied on 21 Jul 2022. was recorded as a recent event.
A charge with Sbicap Trustee Company Limited amounted to Rs. 170.00 Cr with Charge ID 100581744 was registered on 31 May 2022. was recorded as a recent event.
When your cousin gets kicked out of Tata Group but you still got his back and invest in MJ Biopharm, a company that makes insulin. Mehli Mistry, Cyrus' cousin, bought a 20% stake in the company through his own business. He's also invested in PNB MetLife insurance and his own company, M Pallonji & Co, is doing well. He's interested in MJ Biopharm because he's diabetic. The company makes other drugs too and has two factories. The diabetes market in India is worth a lot. Mehli and Cyrus used to be cool but then Cyrus wanted to be fair and transparent with contracts and Mehli didn't like that. But they both deny any drama..
When you team up with MJ Biopharm in India, you can conquer SEA countries with your liquid insulin mouth rinse. #goals #partnership #insulinrevolution.
The CIN of M. J. Biopharm Private Limited is U24234PN2002PTC158855.
M. J. Biopharm Private Limited is headquartered at Plot No. 18, It Park, Hinjawadi Phase Ii, Near Emcure Industrial,, Pune, Maharashtra, 411057.
M. J. Biopharm Private Limited was incorporated on 27 June 2002.
The current directors of M. J. Biopharm Private Limited are
The primary industry of M. J. Biopharm Private Limited is Manufacturing.
M. J. Biopharm Private Limited is unlisted.
The authorized capital of M. J. Biopharm Private Limited is ₹40.00 Cr, and the paid-up capital is ₹23.01 Cr.
The compliance status of M. J. Biopharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX